Showing results (31-40 of 206) with videos related to
Sort By:
Pageof 21
Leukemia|June 27, 2021
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemiaAline Renneville, Mrinal M Patnaik, Onyee Chan, et al.Best Practice & Research. Clinical Haematology|February 11, 2014
Deletion 5q MDS: molecular and therapeutic implicationsRami S Komrokji, Eric Padron, Benjamin L Ebert, et al.Current Opinion in Hematology|January 10, 2015
Current state of prognostication and risk stratification in myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Eric Padron, et al.Clinical Lymphoma, Myeloma & Leukemia|February 1, 2022
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)Onyee Chan, Najla Al Ali, David Sallman, et al.Virology|March 7, 2003
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4Nikola Kaludov, Eric Padron, Lakshmanan Govindasamy, et al.European Journal of Haematology|August 18, 2021
Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomesAmy Song, Omar Altabbakh, David A Sallman, et al.Cancer Genomics & Proteomics|March 3, 2018
Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center ExperienceMohammad Omar Hussaini, Abu-Sayeef Mirza, Rami Komrokji, et al.Journal of Clinical Pathology|November 28, 2019
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndromeIbraahim Badaat, Sabbir Mirza, Eric Padron, et al.Journal of Virology|September 15, 2006
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4Lakshmanan Govindasamy, Eric Padron, Robert McKenna, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic SyndromeMintallah Haider, Najla Al Ali, Eric Padron, et al.Pageof 21